SCHEMBL7101596

SCHEMBL7101596

COc1ccc2cc([C@H](C)C(=O)OCCCN3CCN(CCCO[N+](=O)[O-])CC3)ccc2c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.50
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
DRD2 P14416 1/20 0.47
DRD3 P35462 1/20 0.47
TSHR P16473 2/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
PTGS1 P23219 3/20 0.46
AKR1C3 P42330 2/20 0.46
AKR1C2 P52895 2/20 0.46
CDC42 P60953 1/20 0.46
RAC1 P63000 1/20 0.46
CYP1A2 P05177 1/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7106728 0.99 PTGS2 (0.49) PTGS2TDP1L3MBTL1DRD2DRD3
Hydrochloric Acid SCHEMBL7169819 0.90 PTGS2 (0.44) PTGS2TDP1L3MBTL1DRD2DRD3
SCHEMBL19719469 0.90 PTGS2 (0.57) PTGS2TDP1L3MBTL1TSHRLMNA
Naproxcinod SCHEMBL29663794 0.90 PTGS2 (0.57) PTGS2TDP1L3MBTL1TSHRLMNA
SCHEMBL13730523 0.90 PTGS2 (0.57) PTGS2TDP1L3MBTL1TSHRLMNA
Naproxcinod SCHEMBL1170879 0.90 PTGS2 (0.57) PTGS2TDP1L3MBTL1TSHRLMNA
Naproxcinod SCHEMBL1448284 0.90 PTGS2 (0.57) PTGS2TDP1L3MBTL1TSHRLMNA
SCHEMBL1245933 0.89 PTGS2 (0.56) PTGS2TDP1L3MBTL1TSHRLMNA
SCHEMBL5604761 0.89 PTGS2 (0.56) PTGS2TDP1L3MBTL1TSHRLMNA
SCHEMBL13730950 0.89 PTGS2 (0.56) PTGS2TDP1L3MBTL1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004000300-A1 CYCLOOXYGENASE-2 INHIBITORS NICOX S.A. (FR) 2003-12-31 WO disclosed